Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence

OBJECTIVE: The study aims to assess the cardiovascular safety of growth hormone (GH) treatment in patients with Noonan syndrome (NS) in clinical practice. DESIGN: The study design involves two observational, multicentre studies (NordiNet® IOS and the ANSWER Program) evaluating the long-term effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Alicia, Kaski, Juan Pablo, Dahlgren, Jovanna, Kelepouris, Nicky, Pietropoli, Alberto, Rohrer, Tilman R, Polak, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859970/
https://www.ncbi.nlm.nih.gov/pubmed/34939937
http://dx.doi.org/10.1530/EC-21-0549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859970/
https://www.ncbi.nlm.nih.gov/pubmed/34939937
http://dx.doi.org/10.1530/EC-21-0549

Ejemplares similares